Fresh analysis indicates that patients who discontinue popular GLP-1 drugs like Wegovy and Mounjaro may regain shed pounds far faster than those who end conventional lifestyle regimens.
Published data in a prominent medical journal shows that while obese individuals frequently drop about a fifth of their body weight while on the medication, the weight is regained at an estimated rate of 0.8 kg per month once they quit.
"People buying such medications must be cognizant of the danger of fast rebound weight gain when the treatment concludes," cautioned expert Dr. Susan Jebb.
That rate of recovery implies a return to original weight within about 18 months.
Analyzing Therapies
The study, which looked at dozens of trials involving over 9,000 of participants, compared the outcomes of the injectable medications with older methods.
Scientists note that people who lose weight through lifestyle changes alone generally see a more gradual creep back—approximately 0.1 kg a month—once they finish.
Explaining the Rapid Regain
Doctors propose the mode of action of the injections explains the heightened regain.
The injections copy a natural hormone called GLP-1, which controls appetite.
"Long-term administration of the hormone concentrations far above than normal could lead to the body to generate a reduced amount of its endogenous hormone, and may also reduce responsiveness to its actions," noted Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this medication means appetite is no longer kept in check, making excessive eating far more likely."
An Ongoing Condition?
Medical guidelines advise the injections for individuals with weight-linked health risks, alongside recommended diet and exercise modifications.
Professionals contend that, given the likelihood of relapse, the treatment should be considered life-long.
This view is supported by drug manufacturers, who note that the findings "emphasize the persistent character of excess weight," similar to managing conditions like high blood pressure.
User Testimonies
Users who have discontinued the medication report a intense resurgence of cravings.
"It felt as if a switch flipping and I was suddenly ravenous," said an individual.
This difficulty is compounded if users have not developed lasting dietary or behavioural modifications during therapy.
Significant Adoption
Survey data suggest that millions of people in the UK have used these injections in the past year, with desire being substantial.
- Adoption is higher among females than men.
- The 40s and 50s demographic shows the highest usage rates.
- Many access the drugs through private healthcare rather than public health services.
Ultimately, researchers caution that while these medications are powerful tools for shedding pounds, they are not a permanent fix and maintained weight loss hinges on integrated lifestyle support.